“SIGNALLING PATHWAYS AND MOLECULAR TARGETS FOR SKIN CANCER: INVOLVEMENT OF CDK2 INHIBITION”, NUJPS, vol. 5, no. 1, pp. 41–58, Jun. 2018, doi: 10.5281/.